INSPECS Group plc (AIM:SPEC)
London
· Delayed Price · Currency is GBP · Price in GBX 40.00
+1.00 (2.56%)
Apr 17, 2025, 12:35 PM GMT+1
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 40.67 million as of April 17, 2025. Its market cap has decreased by -18.37% in one year.
Market Cap
40.67M
Enterprise Value
79.18M
Revenue
198.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.00
Market Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 40.67M, a decrease of -70.52%. That is a compound annual growth rate of -21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 40.67M | -12.09% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | 334.26M | 142.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.20B |
| Haleon | 34.56B |
| Smith & Nephew | 8.59B |
| ConvaTec Group | 5.18B |
| Hikma Pharmaceuticals | 4.16B |
| HUTCHMED (China) | 1.81B |
| Oxford Nanopore Technologies | 1.12B |